Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model

Table 2

Antitumor effect of GLY in murine WEHI-3 leukemia model.

Organs	Groups
	Normal control	Untreated group	0.75 g/kg GLY	1.5 g/kg GLY
Tumor		0.57 ± 0.27	0.22 ± 0.07^d	0.21 ± 0.08^c
Liver	1.45 ± 0.08	1.64 ± 0.06^a	1.48 ± 0.08^c	1.47 ± 0.05^d
Spleen	0.09 ± 0.01	0.14 ± 0.03^b	0.14 ± 0.02	0.11 ± 0.02^c

Data was presented as grams weight and expressed as the mean ± SD (𝑛=7). GLY extract was orally administered one time daily for 14 days. Results: ^a𝑃<0.05 versus normal control (without tumor graft), ^b𝑃<0.01 versus normal control, ^c𝑃<0.05 versus untreated group (tumor graft alone), and ^d𝑃<0.01 versus untreated group.